AUTOLUS THERAPEUTICS PLC

Active London
752 employees website.com
Life sciences and medical technology
A

AUTOLUS THERAPEUTICS PLC

Founded 2 Feb 2018 Active London, England 752 employees website.com
Life sciences and medical technology

Previous Company Names

AUTOLUS THERAPEUTICS LIMITED 2 Feb 2018 — 18 Jun 2018
Accounts Submitted 4 Jul 2025 Next due 30 Jun 2026 1 month remaining
Confirmation Submitted 29 Apr 2026 Next due 15 Feb 2027 9 months remaining
Net assets £178M £162M 2025 year on year
Total assets £589M £35M 2025 year on year
Total Liabilities £411M £128M 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Mediaworks 191 Wood Lane London W12 7FP England

Website

www.example.com

Full company profile for AUTOLUS THERAPEUTICS PLC (11185179), an active life sciences and medical technology company based in London, England. Incorporated 2 Feb 2018. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Balance Sheet & P&L (2016–2025)

Cash in Bank

£302.21M

Decreased by £167.64M (-36%)

Net Assets

£178.13M

Decreased by £162.49M (-48%)

Total Liabilities

£410.94M

Increased by £127.65M (+45%)

Turnover

£75.90M

Increased by £67.84M (+841%)

Employees

752

Increased by 289 (+62%)

Debt Ratio

70%

Increased by 25 (+56%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

139 Allotments 331,633,434 Shares £1298.44m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
7 Jul 20255,449$0.229$0
28 Apr 202512,500$0.525$0
16 Jan 20253,648$0.153$0
18 Jun 20245,696$0.239$0
18 Jun 2024291$512.16$1.76

Officers

Officers

2 active 1 resigned
Status
Azelby, Robert WilliamDirectorAmericanUnited States589 Jan 2024Active
Bain, Linda CatharinaDirectorAmericanUnited States5515 Jun 2018Active

Shareholders

Shareholders (3)

National City Nominees Limited Citygroup Centre Canada Square Canary Wharf London United Kingdom E14 5lb
79.5%
200,518,076
National City Nominees Limited Citigroup Centre Canada Square Canary Wharf London England E14 5lb
20.5%
51,582,476

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Matthias Alder

Ceased 15 Jun 2018

Ceased

Group Structure

Group Structure

AUTOLUS THERAPEUTICS PLC Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
29 Apr 2026Confirmation StatementConfirmation statement made on 1 Feb 2026 with no updates
29 Apr 2026OfficersAppointment of Ms Linda Catharina Bain as director
13 Feb 2026CapitalAllotment of shares (GBP 88,004.956778) on 17 Oct 2025
30 Jan 2026OfficersAppointment of Ryan Jeffrey Richardson as director on 1 Dec 2025
7 Jul 2025OfficersTermination of Joseph Anderson as director on 26 Jun 2025
29 Apr 2026 Confirmation Statement

Confirmation statement made on 1 Feb 2026 with no updates

29 Apr 2026 Officers

Appointment of Ms Linda Catharina Bain as director

13 Feb 2026 Capital

Allotment of shares (GBP 88,004.956778) on 17 Oct 2025

30 Jan 2026 Officers

Appointment of Ryan Jeffrey Richardson as director on 1 Dec 2025

7 Jul 2025 Officers

Termination of Joseph Anderson as director on 26 Jun 2025

Recent Activity

Latest Activity

Confirmation statement made on 1 Feb 2026 with no updates

1 weeks ago on 29 Apr 2026

Appointment of Ms Linda Catharina Bain as director

1 weeks ago on 29 Apr 2026

Allotment of shares (GBP 88,004.956778) on 17 Oct 2025

2 months ago on 13 Feb 2026

Appointment of Ryan Jeffrey Richardson as director on 1 Dec 2025

3 months ago on 30 Jan 2026

Termination of Joseph Anderson as director on 26 Jun 2025

10 months ago on 7 Jul 2025